<< DeParle gets GOP cold shoulder on health reform | Amgen receives worldwide rights to Array’s small-molecule glucokinase activator program >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Norsk | Русский | Svenska | Polski

Postmenopausal women who take antidepressants face increased risk for stroke and death

Published on December 14, 2009 at 11:46 PM · 1 Comment

Postmenopausal women who take antidepressants face a small but statistically significant increased risk for stroke and death compared with those who do not take the drugs. The new findings are from the federally-funded, multi-institution, Women's Health Initiative Study sponsored by the National Institutes of Health, and the results are published in the December 14 online edition of Archives of Internal Medicine.

Senior author Sylvia Wassertheil-Smoller, Ph.D., is a principal investigator in the Women's Health Initiative and is division head of epidemiology and professor of epidemiology & population health at Albert Einstein College of Medicine of Yeshiva University. In addition to Einstein, other institutions involved in the study were Massachusetts General Hospital, where the lead author of the paper, Jordan W. Smoller, M.D., Sc.D., is based. He is also associate professor of psychiatry in the Harvard Medical School. Also contributing to the study are researchers from the University of California San Diego, the University of Washington, the University of Hawaii, the University of Iowa, the University of Massachusetts Medical School, and Emory University School of Medicine.

The study examined data from 136,293 study participants, aged 50 to 79, who were not taking antidepressants when they enrolled in the study, and who were followed for an average of six years. Data from 5,496 women who were taking antidepressants at their first follow-up visit were compared with data from 130,797 not taking antidepressants at follow-up. The researchers compared the two groups with respect to the incidence of fatal or nonfatal stroke, fatal or nonfatal heart attack and death due to all causes.

The researchers found no difference in coronary heart disease (defined as fatal and non-fatal heart attacks). However, they did observe a significant difference in stroke rates: antidepressant users were 45 percent more likely to experience strokes than women who weren't taking antidepressants.

The study also found that when overall death rates (all-cause mortality) were compared between the two groups, those on antidepressants had a 32 percent higher risk of death from all causes compared with non-users.

Dr. Wassertheil-Smoller notes that the overall risk for women taking antidepressants is relatively small: a 0.43 percent risk of stroke annually versus a 0.3 percent annual risk of stroke for women not taking antidepressants. However, because antidepressants are among the most widely prescribed drugs in the U.S. - especially among postmenopausal women - small risk increases can have significant implications for large patient populations.

Dr. Wassertheil-Smoller cautioned that "it remains unclear" from the data whether antidepressants are solely responsible for the greater mortality rate among users. The link observed in this study between antidepressant use and increased stroke risk for older women might partially be due to the underlying depression, since several studies have found that depression itself is a risk factor for cardiovascular problems.

Comments
  1. HARVEY  GROVE HARVEY GROVE United States says:

    By what stretch of the imagination can you justify giving a geriatric patient who is approaching the end of life a drug that can speed up the process? Did the patients know these drugs decreased the length of time these patients could expect to live? How many patients survived the bleeding stroke but had a poorer quality of life plus the extra expense of treatment and rehabilitation, if possible, as a result of this therapy. Does a doctor actually believe this risk is worth trying without informing the patient of the actual risks involved to let the patient decide as to whether or not to take the drugs?

    Is this DEATH AND HANDICAP INDUCING THERAPY USED ONLY AFTER ALL OTHER POSSIBILITIES HAVE FAILED? The cavalier attitude of physicians regarding death as JUST ANOTHER "side effect" can not be condoned. Doctors have been exposed to "side effects" for so long that they developed a "matter of fact"  ATTITUDE TOWARDS DEATH AS JUST ANOTHER "POSSIBILITY" THAT ACCOMPANIES TREATMENT. Is this similar to watching so much death and shooting on TV by our children that makes these children inured to death as long as it is not themselves?

    IT APPEARS FDA AND THE DRUG COMPANIES HAVE FOUND A WAY TO GET EXTREMELY DANGEROUS PRODUCTS ON THE MARKET EVEN THOUGH THEY ARE DEATH PRODUCERS. DOCTORS ENJOY BEATING THE GRIM REAPER, HOWEVER, NOW THEY CAN TRY IT WITHOUT THE GUILT OF KNOWING THEY CAUSED THE DEATH OF THEIR PATIENT AS IT IS ONLY A "SIDE EFFECT".

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading